Requirement for IGF-I in epidermal growth factor-mediated cell cycle progression of mammary epithelial cells

Endocrinology

Volumn 143, Issue 5, 2002, Pages 1872-1879

  Stull, Malinda A ^a   Richert, Monica M ^a,b   Loladze, Aimee V ^a   Wood, Teresa L ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLINE; EPIDERMAL GROWTH FACTOR; MITOGENIC AGENT; SOMATOMEDIN C; TRANSFORMING GROWTH FACTOR ALPHA;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BREAST DEVELOPMENT; BREAST EPITHELIUM; CELL CYCLE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CONTROLLED STUDY; DNA SYNTHESIS; FEMALE; METAPHASE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM;

EID: 0036231180     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.143.5.8774     Document Type: Article

References (64)

1. Induction of DNA synthesis in BALB/c3T3 cells by serum components: Reevaluation of the commitment process
2. Dual control of cell growth by somatomedins and platelet-derived growth factor
3. Functional consequences of cyclin D1 overexpression in human mammary luminal epithelial cells
4. Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice
5. Induction of mammary gland hyperplasia and carcinomas in transgenic mice expressing human cyclin E
6. Cyclin D1 overexpression in mouse epidermis increases cyclin-dependent kinase activity and cell proliferation in vivo but does not affect skin tumor development
7. Mice lacking cyclin D1 are small and show defects in eye and mammary gland development
8. Cyclin D1 provides a link between development and oncogenesis in the retina and breast
9. Control of mammary gland development
10. EGF-related peptides and their receptors in mammary gland development
11. Transgenic mice reveal roles for TGFα and EGF receptor in mammary gland development and neoplasia
12. Mammary gland development and tumorigenesis in estrogen receptor knockout mice
13. Use of PRKO mice to study the role of progesterone in mammary gland development
14. Elucidation of a role for stromal steroid hormone receptors in mammary gland growth and development using tissue recombinants
15. Mammary gland growth and development from the postnatal period to postmenopause: Ovarian steroid receptor ontogeny and regulation in the mouse
16. Progesterone signaling and mammary gland morphogenesis
17. The insulin-like growth factors (IGFs) and IGF binding proteins in postnatal development of murine mammary glands
18. IGF-I: An essential factor in terminal end bud formation and ductal morphogenesis
19. Fibroblast growth factor signalling and cyclin D1 function are necesary for normal mammary gland development during pregnancy. A transgenic mouse approach
20. Postnatal mammary gland morphogenesis
21. The mouse waved-2 phenotype results from a point mutation in the EGF receptor tyrosine kinase
22. Targeted expression of a dominant negative epidermal growth factor receptor in the mammary gland of transgenic mice inhibits pubertal mammary duct development
23. Activation and function of the epidermal growth factor receptor and erbB-2 during mammary gland morphogenesis
24. Targeted inactivation of the EGF and amphiregulin genes reveals distinct roles for EGF receptor ligands in mouse mammary gland development
25. Insulin-like growth factor I is essential for terminal end bud formation and ductal morphogenesis during mammary development
26. Stimulation of mammary epithelial cell growth in vitro: Interaction of epidermal growth factor and mammogenic hormones
27. Somatomedin-C substitutes for insulin for the growth of mammary epithelial cells from normal virgin mice in serum-free collagen gel cell culture
28. Ductal morphogenesis in the mouse mammary gland: Evidence supporting a role for epidermal growth factor
29. Effects of estrogen, epidermal growth factor, and transforming growth factor-α on the growth of human breast epithelial cells in primary culture
30. Control of mammary epithelial cell DNA synthesis by epidermal growth factor, cholera toxin, and IGF-1: Specific inhibitory effect of prolactin on EGF-stimulated cell growth
31. Thyrotropin induces G1 cyclin expression and accelerates G1 phase after insulin-like growth factor I stimulation in FRTL-5 cells
32. Insulin-like growth factor-I induces cyclin-D1 expression in MG63 human osteosarcoma cells in vitro
33. Epidermal growth factor induces cyclin D1 in a human prostate cancer cell line
34. Inhibition of basal and mitogen-stimulated pancreatic cancer cell growth by cyclin D1 antisense is associated with loss of tumorigenicity and potentiation of cytotoxicity to cisplatinum
35. The potentiation of estrogen on insulin-like growth factor 1 action in MCF-7 human breast cancer cells includes cell cycle components
36. Reduced cydin D1 expression in the cerebella of nutritionally deprived rats correlates with developmental delay and decreased cellular DNA synthesis
37. 17β-estradiol induces cyclin D1 gene transcription, p36D1-p34cdk4 complex activation and p105Rb phosphorylation during mitogenic stimulation of G(1)-arrested human breast cancer cells
38. Stabilization of cyclin D1 mRNA via the phosphatidylinositol 3-kinase pathway in MCF-7 human breast cancer cells
39. Insulin-like growth factor 1 and oestradiol promote cell proliferation of MCF-7 breast cancer cells: New insights into their synergistic effects
40. Differential regulation of p27 and cyclin D1 by TGF-β and EGF in C3H 10T1/2 mouse fibroblasts
41. Cyclin D1 expression mediated by phosphatidylinositol 3-kinase through mTOR-p70(S6K)-independent signaling in growth factor-stimulated NIH 3T3 fibroblasts
42. Insulin-like growth factor-1 receptor and its ligand regulate the reentry of adult ventricular myocytes into the cell cycle
43. Insulin-like growth factor-I extends in vitro replicative life span of skeletal muscle satellite cells by enhancing G1/S cell cycle progression via the activation of phosphatidylinositol 3′-kinase/Akt signaling pathway
44. The insulin-like growth factors (IGF) and IGF type I receptor during postnatal growth of the murine mammary gland: Sites of messenger ribonucleic acid expression and potential functions
45. Estrogen affects development of alveolar structures in whole-organ culture of mouse mammary glands
46. Role of growth hormone and insulin-like growth factor-I in mammary development
47. Crosstalk between the insulin-like growth factors and estrogens in breast cancer
48. Estrogen receptors: Bioactivities and interactions with cell signaling pathways
49. Activation of estrogen receptor-mediated gene transcription by IGF-I in human breast cancer cells
50. p53 regulates a G2 checkpoint through cyclin B1
51. Mechanisms of G2 arrest in response to overexpression of p53
52. p53-dependent G2 arrest associated with a decrease in cyclins A2 and B1 levels in a human carcinoma cell line
53. Insulin-like growth factor 1 is required for G2 progression in the estradiol-induced mitotic cycle
54. Insulin-like growth factor I-mediated degradation of insulin receptor substrate-1 is inhibited by epidermal growth factor in prostate epithelial cells
55. Effect of a null mutation of the insulin-like growth factor I receptor gene on growth and transformation of mouse embryo fibroblasts
56. Prolonged activation of ERK2 by epidermal growth factor and other growth factors requires a functional insulin-like growth factor 1 receptor
57. IGF-I synergizes with FGF-2 to stimulate oligodendrocyte progenitor entry into the cell cycle
58. Epidermal growth factor requirement for development of cultured mammary gland
59. Insulin-like growth factors, their binding proteins and receptors as growth regulators in normal physiology and pathological states
60. Signaling through the stromal epidermal growth factor receptor is necessary for mammary ductal development
61. Inhibition of mouse mammary ductal morphogenesis and down-regulation of the EGF receptor by epidermal growth factor
62. EGF receptor regulation in normal mouse mammary gland
63. Selective changes in EGF receptor expression and function during the proliferation, differentiation and apoptosis of mammary epithelial cells
64. Targeted disruption of the IGF-I receptor gene decreases cellular proliferation in mammary terminal end buds